GABA Labs
Biotechnology Research
Revolutionising adult social drinking with Alcarelle, our synthetic alcohol alternative.
About us
GABA Labs’ pioneering team of scientists has developed new functional ingredients designed to give social drinkers what they want from alcohol, but without the alcohol. Our first ingredient, “Alcarelle”, is ready to take through the FDA GRAS regulatory pathway in the US. Once the FDA has validated that Alcarelle has successfully completed all the safety tests required, GABA Labs will license Alcarelle to the Drinks Industry, enabling them to create an entirely new generation of beverages for adult social drinkers.
- Website
-
www.gabalabs.com
External link for GABA Labs
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Type
- Privately Held
- Founded
- 2016
- Specialties
- GABA Research, Alcohol alternatives, and GABAergic ingredients
Employees at GABA Labs
-
Ben Brangwyn
-
David Orren
CEO GABA Labs
-
Jennifer Pray
B2B Sales & Partnerships Manager | HR, Recruitment & Administration Specialist
-
Meg Spriggs
Senior Advisor Alzheimers New Zealand | Peer Supporter Life Matters | Research and Lived Experience Consultant | Mental Health Advocate & Writer